Spanish Society of Cardiology Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Madrid Spain (1944)

Organization Overview

First Clinical Trial
2005
NCT00257309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Danish Society of Cardiology | Spanish Society of Cardiology | Spanish Society of Cardiology (WG on Interventional Cardiology) | Spanish Society of Cardiology (WG on Ischemic Heart Disease and CCUs)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aortic Valve Stenosis (Phase 4)

Atrial Fibrillation (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Embolism (Phase 4)

Heart Failure (Phase 3)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Pulmonary Embolism (Phase 4)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thromboembolism (Phase 4)

Venous Thrombosis (Phase 4)

Ventricular Remodeling (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 13